These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23145135)

  • 21. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
    Wu JZ; Yao N; Walker M; Hong Z
    Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of inhibition for BMS-791325, a novel non-nucleoside inhibitor of hepatitis C virus NS5B polymerase.
    Rigat KL; Lu H; Wang YK; Argyrou A; Fanslau C; Beno B; Wang Y; Marcinkeviciene J; Ding M; Gentles RG; Gao M; Abell LM; Roberts SB
    J Biol Chem; 2014 Nov; 289(48):33456-68. PubMed ID: 25301950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
    Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
    Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy.
    Wu JZ; Hong Z
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):207-19. PubMed ID: 14529354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a platform for molecular and immunological characterization of the RNA-dependent-RNA-polymerase NS5B of an Egyptian HCV isolate.
    Gewaid H; Mesalam AA; Ibrahim AA; Abdel Shafy DN; Abdel Shafy RN; Emara N; Hamdy SM; Gewaid M; Bahgat MM
    J Med Virol; 2018 Mar; 90(3):545-558. PubMed ID: 29064582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
    Lee KJ; Choi J; Ou JH; Lai MM
    J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus.
    Glab-Ampai K; Chulanetra M; Malik AA; Juntadech T; Thanongsaksrikul J; Srimanote P; Thueng-In K; Sookrung N; Tongtawe P; Chaicumpa W
    Sci Rep; 2017 Nov; 7(1):15042. PubMed ID: 29118372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C Virus NS5B polymerase.
    Lemm JA; Liu M; Gentles RG; Ding M; Voss S; Pelosi LA; Wang YK; Rigat KL; Mosure KW; Bender JA; Knipe JO; Colonno R; Meanwell NA; Kadow JF; Santone KS; Roberts SB; Gao M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3485-95. PubMed ID: 24733465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-induced changes in hepatitis C virus NS5B polymerase structure.
    Rigat K; Wang Y; Hudyma TW; Ding M; Zheng X; Gentles RG; Beno BR; Gao M; Roberts SB
    Antiviral Res; 2010 Nov; 88(2):197-206. PubMed ID: 20813137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis.
    Vo NV; Tuler JR; Lai MM
    Biochemistry; 2004 Aug; 43(32):10579-91. PubMed ID: 15301555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed computational study of the active site of the hepatitis C viral RNA polymerase to aid novel drug design.
    Barakat KH; Law J; Prunotto A; Magee WC; Evans DH; Tyrrell DL; Tuszynski J; Houghton M
    J Chem Inf Model; 2013 Nov; 53(11):3031-43. PubMed ID: 24116674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage.
    Devogelaere B; Berke JM; Vijgen L; Dehertogh P; Fransen E; Cleiren E; van der Helm L; Nyanguile O; Tahri A; Amssoms K; Lenz O; Cummings MD; Clayton RF; Vendeville S; Raboisson P; Simmen KA; Fanning GC; Lin TI
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4676-84. PubMed ID: 22710121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV antiviral resistance: the impact of in vitro studies on the development of antiviral agents targeting the viral NS5B polymerase.
    Tomei L; Altamura S; Paonessa G; De Francesco R; Migliaccio G
    Antivir Chem Chemother; 2005; 16(4):225-45. PubMed ID: 16130521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.
    Graham DJ; Stahlhut M; Flores O; Olsen DB; Hazuda DJ; Lafemina RL; Ludmerer SW
    Antiviral Res; 2006 Jan; 69(1):24-30. PubMed ID: 16297457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase.
    Howe AY; Bloom J; Baldick CJ; Benetatos CA; Cheng H; Christensen JS; Chunduru SK; Coburn GA; Feld B; Gopalsamy A; Gorczyca WP; Herrmann S; Johann S; Jiang X; Kimberland ML; Krisnamurthy G; Olson M; Orlowski M; Swanberg S; Thompson I; Thorn M; Del Vecchio A; Young DC; van Zeijl M; Ellingboe JW; Upeslacis J; Collett M; Mansour TS; O'Connell JF
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4813-21. PubMed ID: 15561861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
    Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
    Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
    J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives.
    Rawal RK; Katti SB; Kaushik-Basu N; Arora P; Pan Z
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6110-4. PubMed ID: 18947995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.